Back

Usefulness of left ventricular end-systolic elastance calculated non-invasively for predictor of tachycardia-induced cardiomyopathy at heart failure-reduced ejection fraction

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Atrial Fibrillation - Epidemiology, Prognosis, Outcome Heart Failure in Atrial Fibrillation EHRA Premium Access EHRA 2019

About the speaker

Photo
Doctor Masao Takahashi

Tokyo Metropolitan Hiroo Hospital, Tokyo (Japan)

8 More presentations in this session

Presentation thumbnail
The association between insulin resistance and incidence of atrial fibrillation in non-diabetics: findings from Ansung-Ansan cohort of the national genome and epidemiology study
Associate Professor J. Park (Seoul, KR)
Abstract Slides
Presentation thumbnail
Difference of symptom characteristics of atrial fibrillation in patients with concomitant left ventricular dysfunction
Associate Professor J. Park (Seoul, KR)
Abstract Slides
Presentation thumbnail
Left atrial size and function in atrial fibrillation progression
Doctor T. Seewoester (Leipzig, DE)
Abstract
Presentation thumbnail
Do DDD pacemakers increase the incidence of atrial fibrillation?
Doctor P. Amador (Setubal, PT)
Abstract Slides
Presentation thumbnail
Long term impact of metabolic syndrome management on mortality in patients with atrial fibrillation
Associate Professor Y. Baek (Incheon, KR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 3 - Atrial Fibrillation - Epidemiology, Prognosis, Outcome

The Event

Event poster

EHRA 2019

17 March - 19 March 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources